This session contains links to financial disclosure, information meeting, press conference, and other presentation materials and movie files.
Eisai Presentation Material
Annual Financial Results for the Fiscal Year Ended March 31, 2018
| Date / Time |
Tuesday, May 15, 2018 16:00 - 17:00 (JST) |
|---|---|
| Location |
Corporate Headquarters, Eisai Co., Ltd., Tokyo, JAPAN |
| Representative Corporate Officer and CEO |
Haruo Naito |
<Media Conference>
Strategic Alliance for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd.
| Date / Time |
Thursday, March 29, 2018 11:00 - 12:00 (JST) |
|---|---|
| Location |
Yamabuki Ballroom, 4th Floor, Palace Hotel Tokyo |
| Presenter |
Yuichi Tamura, President and CEO, Nichi-Iko Pharmaceutical Co., Ltd. |
Information Meeting 2018
| Date / Time |
Friday, March 9, 2018 4:00pm - 5:30pm (JST) |
|---|---|
| Location |
Corporate Headquarters, Eisai Co., Ltd., Tokyo, JAPAN |
| Representative Corporate Officer and CEO |
Haruo Naito |
Press Conference 2018
| Date / Time |
Thursday, March 8, 2018 4:00pm - 5:30pm (JST) |
|---|---|
| Location |
Corporate Headquarters, Eisai Co., Ltd., Tokyo, JAPAN |
| Representative Corporate Officer and CEO |
Haruo Naito |
<The Media/Investor Conference>
Eisai Co,. Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Execution of Comprehensive Strategic Collaboration for Eisai's In-house Discovered Anticancer Agent LENVIMA
| Date / Time |
Thursday, March 8, 2018 13:00 - 14:00 (JST) |
|---|---|
| Location |
Corporate Headquarters, Eisai Co., Ltd., Tokyo, JAPAN |
| Representative Corporate Officer and CEO |
Haruo Naito |
You can listen to a replay of the press conference from the following link
Past Eisai Presentation Materials